Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation

International Journal of Cancer

Volumn 92, Issue 4, 2001, Pages 577-582

  Bilkenroth, Udo ^a   Taubert, Helge ^a   Riemann, Dagmar ^a   Rebmann, Udo ^a   Heynemann, Hans ^b   Meye, Axel ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Diakonissenanstalt   (Germany)

Author keywords

Cytokeratin; Disseminated tumor cells; Magnetic cell sorting (MACS); Minimal residual disease; Renal cell carcinoma

Indexed keywords

CYTOKERATIN;

ARTICLE; CANCER GRADING; CANCER STAGING; CELL COUNT; CELL SELECTION; CELL SEPARATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD45; CELL SEPARATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; MAGNETICS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0035874052     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1217     Document Type: Article

References (39)

1. Über das vorkommen von tumorzellen im zirkulierenden blut
2. Cancer cells in the peripheral blood: A second look
3. Nucleic acid based techniques for the detection of rare cancer cells in clinical samples
4. Disseminierte tumorzellen: Diagnostik, prognostische relevanz, phänotypisierung and therapeutische strategien
5. Detection and clinical importance of micrometastatic disease
6. Disseminated tumor cells versus micrometastasis: Definitions and problems
7. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: A new prognostic factor
8. Detection of breast cancer cells using magnetic cell separation (MACS) system: Implications for stem cell purging
9. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS
10. Increased sensitivity for detection of micrometastases in bonemarrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
11. Detection and characterization of carcinoma cells in the blood
12. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics
13. Improvement of breast cancer cell detection by immunomagnetic enrichment
14. Detection of circulating tumor cells in colorectal cancer by immuno-bead-PCR is a sensitive prognostic marker for relapse of disease
15. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
16. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer
17. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC
18. Detection of circulating melanoma cells by immunomagnetic cell sorting
19. Prognostic relevance of micrometastatic tumor cells in bone marrow of patients with genitourinary tract tumors
20. The detection of renal cells carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9
21. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histomorphological elements and their use for diagnostics
22. The catalog of human cytokeratins: Pattern of expression in normal epithelial, tumors and cultured cells
23. HEA 125 and BerEP4: Two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors
24. Nucleic acid-based methods for the detection of cancer
25. Multiple mutation analyses in single tumor cells with improved whole genome amplification
26. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
27. Enrichment of epithelial cells for molecular studies
28. Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR
29. Isolation by size of epithelial tumor cells
30. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
31. Limitations of reverse-transcriptase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
32. Detection of disseminated prostate cells by reverse transcription-polymerase chain reaction (RT-PCR): Technical and clinical aspects
33. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: A quality-assurance initiative of the EORTC Melanoma Cooperative Group
34. CK20 gene expression: Technical limits for the detection of circulating tumor cells
35. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
36. Detection of circulating tumour cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential hazard for intraoperative hematogenous tumor cell dissemination
37. Micrometastases: Marker of metastatic potential or evidence of residual disease
38. Circadian coordination of cancer growth and metastatic spread